135 related articles for article (PubMed ID: 27912737)
1. HCV prevalence can predict HIV epidemic potential among people who inject drugs: mathematical modeling analysis.
Akbarzadeh V; Mumtaz GR; Awad SF; Weiss HA; Abu-Raddad LJ
BMC Public Health; 2016 Dec; 16(1):1216. PubMed ID: 27912737
[TBL] [Abstract][Full Text] [Related]
2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
[TBL] [Abstract][Full Text] [Related]
3. HIV among people who inject drugs in the Middle East and North Africa: systematic review and data synthesis.
Mumtaz GR; Weiss HA; Thomas SL; Riome S; Setayesh H; Riedner G; Semini I; Tawil O; Akala FA; Wilson D; Abu-Raddad LJ
PLoS Med; 2014 Jun; 11(6):e1001663. PubMed ID: 24937136
[TBL] [Abstract][Full Text] [Related]
4. Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North Africa.
Mumtaz GR; Weiss HA; Vickerman P; Larke N; Abu-Raddad LJ
AIDS; 2015 Aug; 29(13):1701-10. PubMed ID: 26372281
[TBL] [Abstract][Full Text] [Related]
5. Potential geographic "hotspots" for drug-injection related transmission of HIV and HCV and for initiation into injecting drug use in New York City, 2011-2015, with implications for the current opioid epidemic in the US.
Des Jarlais DC; Cooper HLF; Arasteh K; Feelemyer J; McKnight C; Ross Z
PLoS One; 2018; 13(3):e0194799. PubMed ID: 29596464
[TBL] [Abstract][Full Text] [Related]
6. Estimating the impact of a police education program on hepatitis C virus transmission and disease burden among people who inject drugs in Tijuana, Mexico: A dynamic modeling analysis.
Rivera Saldana CD; Abramovitz D; Beletsky L; Borquez A; Kiene S; Marquez LK; Patton T; Strathdee S; Zúñiga ML; Martin NK; Cepeda J
Addiction; 2023 Sep; 118(9):1763-1774. PubMed ID: 37039246
[TBL] [Abstract][Full Text] [Related]
7. Global systematic review and ecological analysis of HIV in people who inject drugs: National population sizes and factors associated with HIV prevalence.
Larney S; Leung J; Grebely J; Hickman M; Vickerman P; Peacock A; Stone J; Trickey A; Dumchev KV; Colledge S; Cunningham EB; Lynskey M; Mattick RP; Degenhardt L
Int J Drug Policy; 2020 Mar; 77():102656. PubMed ID: 31951926
[TBL] [Abstract][Full Text] [Related]
8. The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling study.
Stone J; Artenie A; Hickman M; Martin NK; Degenhardt L; Fraser H; Vickerman P
Lancet Public Health; 2022 Feb; 7(2):e136-e145. PubMed ID: 35012711
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention.
Wiessing L; Ferri M; Grady B; Kantzanou M; Sperle I; Cullen KJ; ; Hatzakis A; Prins M; Vickerman P; Lazarus JV; Hope VD; Matheï C
PLoS One; 2014; 9(7):e103345. PubMed ID: 25068274
[TBL] [Abstract][Full Text] [Related]
10. The contribution of injection drug use to hepatitis C virus transmission globally, regionally, and at country level: a modelling study.
Trickey A; Fraser H; Lim AG; Peacock A; Colledge S; Walker JG; Leung J; Grebely J; Larney S; Martin NK; Hickman M; Degenhardt L; May MT; Vickerman P
Lancet Gastroenterol Hepatol; 2019 Jun; 4(6):435-444. PubMed ID: 30981685
[TBL] [Abstract][Full Text] [Related]
11. HIV incidence among people who inject drugs in the Middle East and North Africa: mathematical modelling analysis.
Mumtaz GR; Awad SF; Feizzadeh A; Weiss HA; Abu-Raddad LJ
J Int AIDS Soc; 2018 Mar; 21(3):e25102. PubMed ID: 29577623
[TBL] [Abstract][Full Text] [Related]
12. Associations between the prevalence of chronic hepatitis B among people who inject drugs and country-level characteristics: An ecological analysis.
Syangbo A; Hickman M; Colledge-Frisby S; Leung J; Grebely J; Larney S; Degenhardt L; Trickey A
Drug Alcohol Rev; 2023 Mar; 42(3):569-581. PubMed ID: 36600489
[TBL] [Abstract][Full Text] [Related]
13. Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections.
Lansky A; Finlayson T; Johnson C; Holtzman D; Wejnert C; Mitsch A; Gust D; Chen R; Mizuno Y; Crepaz N
PLoS One; 2014; 9(5):e97596. PubMed ID: 24840662
[TBL] [Abstract][Full Text] [Related]
14. Harm reduction program and hepatitis C prevalence in people who inject drugs (PWID) in Iran: an updated systematic review and cumulative meta-analysis.
Rajabi A; Sharafi H; Alavian SM
Harm Reduct J; 2021 Jan; 18(1):12. PubMed ID: 33482831
[TBL] [Abstract][Full Text] [Related]
15. Mathematical modeling of hepatitis c virus (HCV) prevention among people who inject drugs: A review of the literature and insights for elimination strategies.
Pitcher AB; Borquez A; Skaathun B; Martin NK
J Theor Biol; 2019 Nov; 481():194-201. PubMed ID: 30452959
[TBL] [Abstract][Full Text] [Related]
16. Can HIV and Hepatitis C Virus Infection be Eliminated Among Persons Who Inject Drugs?
Perlman DC; Des Jarlais DC; Feelemyer J
J Addict Dis; 2015; 34(2-3):198-205. PubMed ID: 26075647
[TBL] [Abstract][Full Text] [Related]
17. Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis.
Cepeda JA; Vickerman P; Bruneau J; Zang G; Borquez A; Farrell M; Degenhardt L; Martin NK
Drug Alcohol Depend; 2020 Aug; 213():108135. PubMed ID: 32603976
[TBL] [Abstract][Full Text] [Related]
18. Overlapping epidemics of alcohol and illicit drug use among HCV-infected persons who inject drugs.
Irvin R; Chander G; Falade-Nwulia O; Astemborski J; Starbird L; Kirk GD; Sulkowski MS; Thomas DL; Mehta SH
Addict Behav; 2019 Sep; 96():56-61. PubMed ID: 31035079
[TBL] [Abstract][Full Text] [Related]
19. Transitions from injection-drug-use-concentrated to self-sustaining heterosexual HIV epidemics: patterns in the international data.
Des Jarlais DC; Feelemyer JP; Modi SN; Arasteh K; Mathers BM; Degenhardt L; Hagan H
PLoS One; 2012; 7(3):e31227. PubMed ID: 22396729
[TBL] [Abstract][Full Text] [Related]
20. A review of network simulation models of hepatitis C virus and HIV among people who inject drugs.
Bellerose M; Zhu L; Hagan LM; Thompson WW; Randall LM; Malyuta Y; Salomon JA; Linas BP
Int J Drug Policy; 2021 Feb; 88():102580. PubMed ID: 31740175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
